FGF7 and prostate cancer: Indeed, orthogonal validation of the FOS and FGF7 5′-UTR mutations in human prostate cancer cells revealed that these single-nucleotide alterations identified through PLUMAGE were sufficient to increase gene-specific transcript levels (Fig. 4b).